Following Bipartisan Push From Sen. Hassan, Federal Agencies Take Action to Lower Prescription Drug Costs
July 08, 2022
July 08, 2022
WASHINGTON, July 8 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release and letter:
Following a bipartisan push from Senator Maggie Hassan (D-NH) and Senator Bill Cassidy (R-LA), the Patent and Trademark Office (PTO) and Food and Drug Administration (FDA) have announced that they will work to close oversight gaps that delay generic drug approvals - and in turn keep drug prices high. Senators Hassan and Cassidy recently wrote a letter to the agencies calling for . . .
Following a bipartisan push from Senator Maggie Hassan (D-NH) and Senator Bill Cassidy (R-LA), the Patent and Trademark Office (PTO) and Food and Drug Administration (FDA) have announced that they will work to close oversight gaps that delay generic drug approvals - and in turn keep drug prices high. Senators Hassan and Cassidy recently wrote a letter to the agencies calling for . . .